As of 09-Oct-2026
2QCY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 20.3B
6MCY26: Rs 38.0B (+4.4%)
Net profit
Rs 2.2B
6MCY26: Rs 4.1B (+16.9%)
EPS
Rs 22.47
6MCY26: Rs 42.29 (+16.9%)
DPS
Rs 0.00
6MCY26: Rs 0.00
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
76.72M (78.37%)
Free Float shares
21.18M (21.63%)
Market Cap
90.70B
#2 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to ABOT by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | 316.6 | Rs 99.6B | 9.6x | 6.1% |
| ABOT Abbott Laboratories (Pakistan (this stock) | 926.5 | Rs 90.5B | 10.5x | 4.3% |
| HALEON Haleon Pakistan | 685.4 | Rs 78.9B | 12.1x | 4.5% |
| HINOON Highnoon Laboratories | 929.1 | Rs 49.2B | 11.8x | 5.4% |
| SEARL The Searle Company | 77.86 | Rs 45.6B | 104.4x | - |
| AGP AGP | 155.48 | Rs 43.8B | 11.9x | 5.1% |
| HPL Hoechst Pakistan | 3,961.82 | Rs 38.1B | 10.1x | 6.8% |
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products. Abbott Laboratories (Pakistan) Limited (ABOT) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.
Abbott Laboratories (Pakistan) Limited (ABOT) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare ABOT with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
